Cadila falls on earnings, broker downgrades
MUMBAI (Reuters) - Cadila Healthcare (CADI.NS) shares fell as much as 8.9 percent after October-December earnings disappointed on Friday, followed by broker downgrades.
Cadila said its December quarter net profit fell by 30.9 percent to 1.03 billion rupees.
Credit Suisse downgraded the stock to "neutral" from "outperform", citing delay in contribution from higher margin products.
(Reporting by Abhishek Vishnoi; Editing by Jijo Jacob)
- Tweet this
- Share this
- Digg this
- 'Plastic' Halloween skulls found in Connecticut are human remains
- Individual genetic differences may affect Ebola survival - study
- UPDATE 1-J.P. Morgan found hackers through breach of corporate event website -media
- Army officer takes charge in Burkina Faso, ousting general
- Test flight of Virgin Galactic spaceship ends in fatal crash in California
Shares Hit Record
The BSE Sensex and Nifty surged to record highs for a second consecutive session on Friday after Bank of Japan's surprise expansion of its massive stimulus programme raised hopes for additional foreign inflows, boosting blue-chips such as Larsen & Toubro. Full Article
China's shadow banking sector growing rapidly, third largest in world - FSB. Full Article